Burns DK, Alexander RC, Welsh-Bohmer KA, Culp M, et al. Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial. Lancet Neurol 2021;20:537-547.
PMID: 34146512